Top biotech licensing deals of Q1 2023 — Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026 — Clinical trial diversity craters out to lowest level in 10 years -- See more on our front page news http://bit.ly/w28kSd #licensing #pfizer #bristolmyerssquibb #medicare #cms #inflationreductionact #drugpricing #clinicaltrials #clinicaltrialdiversity #diversity #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#licensing #pfizer #bristolmyerssquibb #medicare #cms #InflationReductionAct #drugpricing #clinicaltrials #clinicaltrialdiversity #diversity #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma